Gastrointestinal · Drug monograph
Loperamide: veterinary dose and monograph
Loperamide is a veterinary gastrointestinal drug. An opioid (mu-agonist) ANTIDIARRHOEAL that acts LOCALLY on the gut to slow motility and reduce secretion, with minimal central opioid effect at normal doses in healthy dogs (it is normally pumped out of the CNS by P-glycoprotein). Indications include acute, non-infectious / secretory diarrhoea in dogs (short-term symptomatic control); reduction of faecal volume/frequency where appropriate (e.g. some chronic enteropathies, adjunct). This monograph lists 4 reference doses for dogs, cats, rabbits and small mammals, each with route, frequency and source.
At a glance
- Drug class
- Gastrointestinal
- Also known as
- Imodium, Eldoper, Roko
- Species with doses
- Dogs, Cats, Rabbits and Small mammals
- General dose range
- 0.1–0.2 mg/kg PO q8–12h (short term) — check the species tables for the indication
- Routes
- PO
- Last reviewed
- 1 October 2026
Indications
- Acute, non-infectious / secretory diarrhoea in dogs (short-term symptomatic control)
- Reduction of faecal volume/frequency where appropriate (e.g. some chronic enteropathies, adjunct)
Loperamide dose by species
Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.
Dogs
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Acute non-infectious diarrhoea (short term) | 0.08–0.2 mg/kg | PO | q8–12h × ≤5 days | — |
- Acute non-infectious diarrhoea (short term): Papich 5e: 0.12 mg/kg PO q8–12h. Plumb’s p.740: 0.08 mg/kg PO q8h (DeNovo; Washabau); 0.1–0.2 mg/kg PO q8–12h (Willard); 0.1 mg/kg q8h for no more than 5 days (Hall & Simpson). Avoid in MDR1 (ABCB1) breeds — neurotoxicity — and in suspected infectious diarrhoea.
Cats
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Diarrhoea (short term, caution) | 0.08–0.16 mg/kg | PO | q12h | — |
- Diarrhoea (short term, caution): Papich 5e and Plumb’s p.740 (Willard 2003): 0.08–0.16 mg/kg PO q12h; suspension 0.04–0.06 mg/kg q12h (Tams). Opioid antidiarrhoeals are controversial in cats — may cause excitement.
Rabbits
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Diarrhoea | 0.1 mg/kg | PO | q8h × 3 days, then q24h × 2 days | — |
- Diarrhoea: Plumb’s p.740 (Ivey & Morrisey 2000): 0.1 mg/kg in 1 mL water PO q8h for 3 days, then once daily for 2 days.
Small mammals
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Diarrhoea | 0.1 mg/kg | PO | q8h × 3 days, then q24h × 2 days | — |
- Diarrhoea: Plumb’s p.740 (Adamcak & Otten 2000): mice, rats, gerbils, hamsters, guinea pigs, chinchillas 0.1 mg/kg in 1 mL water PO q8h for 3 days, then once daily for 2 days.
Contraindications
MDR1-mutant herding breeds (Collies, Aussies, etc. — opioid CNS toxicity). Infectious/toxin-mediated diarrhoea (slowing motility traps pathogens/toxins — can worsen). Cats (opioid excitation/sensitivity — generally avoid). Suspected GI obstruction. Very young/debilitated animals. Known opioid hypersensitivity.
Species-specific warnings
Dogs: Contraindicated in MDR1 (ABCB1-1Δ) breeds — Collies, Australian Shepherds, etc. — where it causes opioid CNS toxicity at normal doses. Consider MDR1 testing in herding breeds.
Cats: Generally avoid in cats (opioid excitation/sensitivity); use cat-appropriate management of diarrhoea instead.
Adverse effects
- Constipation, bloating, sedation
- CNS/opioid toxicity in MDR1 breeds (sedation, ataxia, respiratory depression) at normal doses
- Excitation in cats
- Worsening of infectious diarrhoea (toxin/pathogen retention)
Drug interactions
- P-glycoprotein inhibitors (ketoconazole, ciclosporin, etc.): increased CNS penetration/toxicity
- Other CNS depressants/opioids: additive central effects (especially if CNS exposure occurs)
- No major other interactions at gut-local doses
Pregnancy and lactation
Limited data; generally avoided unless clearly needed and short-term.
Monitoring
- Diarrhoea response (short-term only — reassess if not resolving / if infectious cause suspected)
- CNS signs (especially in any herding breed — but ideally just avoid in MDR1 breeds)
- Constipation with continued use
Toxicity and overdose
In normal dogs, overdose causes constipation, sedation and (at high doses) opioid CNS/respiratory depression. In MDR1-deficient dogs, even standard doses can cause profound opioid neurotoxicity (sedation, ataxia, drooling, respiratory depression). Cats are prone to opioid excitation. Slowing motility in infectious diarrhoea can worsen the disease.
Management: Antidote: NALOXONE reverses the opioid effects (may need repeating). Supportive care, monitor respiration; decontaminate large recent ingestions. In MDR1 dogs, anticipate prolonged effects and provide supportive care/ventilatory support as needed.
Clinical pearls
- A short-term symptomatic antidiarrhoeal for NON-infectious canine diarrhoea — it slows the gut locally
- NEVER in MDR1/herding breeds (Collies, Aussies) — standard doses cause opioid neurotoxicity; naloxone is the antidote
- Avoid in infectious/toxin diarrhoea (you trap the pathogen/toxin) and in cats
- Use briefly and address the underlying cause; constipation signals you've given enough
Mechanism of action
A peripherally selective mu-opioid agonist that acts on opioid receptors in the intestinal myenteric plexus, slowing propulsive motility, increasing transit time, and reducing intestinal secretion — the antidiarrhoeal effect. Normally it does not reach the CNS because P-glycoprotein (the ABCB1 gene product) pumps it back out of the blood–brain barrier; MDR1-deficient dogs lack this protection, so the drug accumulates centrally and causes opioid neurotoxicity.
Formulations and products
- 2 mg capsule/tablet
- Oral solution 0.2 mg/mL (1 mg/5 mL)
- Imodium — 2 mg capsule, Capsule (human-label)
- Eldoper / Roko — 2 mg tablet/capsule, Tablet / capsule (human-label)
Storage
Capsules/solution: 15–30 °C, dry, protect from light.
Before you use this dose
Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.
Frequently asked questions
What is the dose of Loperamide for dogs?
Reference doses for Loperamide in dogs: 0.08–0.2 mg/kg PO q8–12h × ≤5 days (Acute non-infectious diarrhoea (short term)). Confirm against the label and the patient before use.
What is the dose of Loperamide for cats?
Reference doses for Loperamide in cats: 0.08–0.16 mg/kg PO q12h (Diarrhoea (short term, caution)). Confirm against the label and the patient before use.
What is the dose of Loperamide for rabbits?
Reference doses for Loperamide in rabbits: 0.1 mg/kg PO q8h × 3 days, then q24h × 2 days (Diarrhoea). Confirm against the label and the patient before use.
When should Loperamide not be used?
MDR1-mutant herding breeds (Collies, Aussies, etc. — opioid CNS toxicity). Infectious/toxin-mediated diarrhoea (slowing motility traps pathogens/toxins — can worsen). Cats (opioid excitation/sensitivity — generally avoid). Suspected GI obstruction. Very young/debilitated animals. Known opioid hypersensitivity.
What are the side effects of Loperamide in animals?
Constipation, bloating, sedation; CNS/opioid toxicity in MDR1 breeds (sedation, ataxia, respiratory depression) at normal doses; Excitation in cats; Worsening of infectious diarrhoea (toxin/pathogen retention).
Sources
- Plumb's Veterinary Drug Handbook
- Merck Veterinary Manual, 11th edition
- Papich, Papich Handbook of Veterinary Drugs, 5th edition
Last reviewed · VetMasterJi